Smiths Group PLC · LSE:SMIN

Smiths — J.P. Morgan Cazenove Capital Goods CEO Conference 2010

16 slides from Smiths's conference presentation, Jun 4, 2010

  1. Slide 1: J.P.Morgan Cazenove Capital Goods CEO Conference

    J.P.Morgan Cazenove Capital Goods CEO Conference Philip Bowman, Chief Executive Smiths Group plc J.P.Morgan Cazenove Capital Goods CEO Conference June 2010 | 1 investor.relations@smiths.com

  2. Slide 2: Forward-looking statements

    This presentation contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from tho

  3. Slide 3: Smiths Group at a glance

    Smiths Group at a glance 2009 Full year figures Divisional sales % 8 19 Sales £2.7bn $4.2bn 12 Smiths Detection Operating margin 16% John Crane Smiths Medical EPS 72.4p $1.14 Smiths Interconnect Market cap* £4.0bn $5.9bn Flex-Tek 31 30 Smiths John Crane Smiths Smiths Flex-Tek Detection Medical Inter

  4. Slide 4: Smiths Group: Opportunities to create value

    Smiths Group: Opportunities to create value • Improve margins through restructuring and Delivering ‘self-help’ programs operational efficiencies • Upgrade our business systems to drive faster data-based decisions and leverage scale • Continue to reduce working capital as percentage Cash of sales gen

  5. Slide 5: Further scope for operational efficiencies and self-help

    Further scope for operational efficiencies and self-help Restructuring programme to deliver £50m of savings • Delivered £27m of savings to date – half way through a 3 year programme • Self-help initiatives to drive operational efficiencies Improvement of business systems • Good progress on ERP syste

  6. Slide 6: Delivering further margin improvement

    Delivering further margin improvement First half margins have reached a ten-year high 16.2% Smiths Group plc J.P.Morgan Cazenove Capital Goods CEO Conference June 2010 | 6

  7. Slide 7: Improved operating cash conversion

    Improved operating cash conversion • Focus on improved working capital management • Particularly inventories and debtors • Cash conversion remained strong in Q3 FY10 Smiths Group plc J.P.Morgan Cazenove Capital Goods CEO Conference June 2010 | 7

  8. Slide 8: Investing in increased R&D to launch new products

    Investing in increased R&D to launch new products Increase in both company-funded and customer-funded R&D Smiths Group plc J.P.Morgan Cazenove Capital Goods CEO Conference June 2010 | 8

  9. Slide 9: Improving the portfolio: Overview of M&A activity over past three years

    Improving the portfolio: Overview of M&A activity over past three years Sales Complementary Extending Leveraging Date £m technologies geography infrastructure John Crane Sartorius Nov 07 £14m    John Crane Japan* Dec 07 £16m  Indufil Apr 08 £25m   Fiberod May 08 £12m   Orion May 09 £31

  10. Slide 10: Smiths Detection: Sales growth and margin improvement

    Smiths Detection: Sales growth and margin improvement 2010 H1 Sales: £266m 2010 H1 sales % 2009 Sales: £501m Operating profit: £39m 19% of Group sales Transportation 14.5% margin Ports & borders Military Long-term market drivers: Emergency responders • Threats, legislation and new technologies Criti

  11. Slide 11: John Crane: Margins benefiting from restructuring programme

    John Crane: Margins benefiting from restructuring programme 2010 H1 Sales: 358m 2010 H1 sales % 2009 Sales: £790m Operating profit: £64m 30% of Group sales First-fit OEM 37% 17.9% margin Aftermarket 63% Oil, gas & petrochemical Long-term market drivers: Chemical and pharma • Demand for energy; after

  12. Slide 12: Smiths Medical: Delivering positive sales momentum and margin growth

    Smiths Medical: Delivering positive sales momentum and margin growth 2010 H1 Sales: £414m 2010 H1 sales % 2009 Sales: £834m Operating profit: £86m 31% of Group sales Medication Delivery 20.9% margin Vital Care Safety Devices Long-term market drivers: • Ageing populations, disposable income and legis

  13. Slide 13: Smiths Interconnect: Delivering margin growth; launching new products

    Smiths Interconnect: Delivering margin growth; launching new products 2010 H1 Sales: £146m 2010 H1 sales % 2009 Sales: £318m Operating profit: £23m 12% of Group sales Military/Aerospace 16.0% margin Wireless Medical, rail and automation Long-term market drivers: • Defence spend on military communica

  14. Slide 14: Flex-Tek: Leveraged to a recovery in US residential construction

    Flex-Tek: Leveraged to a recovery in US residential construction 2010 H1 Sales: £96m 2010 H1 sales % 2009 Sales: £96m Operating profit: £9m 8% of Group sales Aerospace 9.8% margin Flexible Solutions Heat Solutions Long-term market drivers: • US residential construction and GDP • Aerospace demand for

  15. Slide 15: Smiths Group: Opportunities to create value

    Smiths Group: Opportunities to create value • Improve margins through restructuring and Delivering ‘self-help’ programs operational efficiencies • Upgrade our business systems to drive faster data-based decisions and leverage scale • Continue to reduce working capital as percentage Cash of sales gen

  16. Slide 16: Questions?

    Questions? 2010 Investor Days Smiths Interconnect - Tampa, FL – June 22 Smiths Medical - St Paul, MN – June 23 Smiths Group plc J.P.Morgan Cazenove Capital Goods CEO Conference June 2010 | 16 investor.relations@smiths.com

Smiths Group — J.P. Morgan Cazenove Capital Goods CEO Conference 2010 on 6ix